2 hours ago
6
For some of the most aggressive blood cancers, a stem cell transplant may be the only treatment with the potential to cure the disease. Even so, cancers can return after transplantation, leaving doctors with limited options.
A new clinical trial led by researchers at Washington University School of Medicine in St. Louis suggests that genetically modifying donor stem cells before transplantation could make follow-up cancer treatments safer and potentially more ...
English (US) ·